Sci-Group has developed a groundbreaking freezing technology that enables cryopreservation of cells entirely without or significantly reduced the use of cytotoxic chemical cryoprotectants or complicated freezing and thawing processes.
With our solution, cells can be safely and efficiently frozen and later used as needed — while minimizing exposure to cytotoxic substances and simplifying handling.
Sci-Group is a Norwegian deep tech company dedicated to transforming the global cryopreservation industry. Our patented technology, CryoEmbla, enables the safe, rapid, and efficient freezing of living cells — without, or with strongly reduced, use of DMSO or other cytotoxic chemical cryoprotectants.
At the core of Sci-Group’s business is the development and commercialization of innovative, research-based solutions that address critical challenges in cell therapy, biotechnology, and life sciences. By eliminating toxic additives and simplifying workflows, CryoEmbla opens new opportunities for safer cell therapies, biobanking, and advanced research—enabling broader clinical and industrial use of living cells.
We work closely with leading research institutions, industry partners, and investors to accelerate the adoption of next-generation cryopreservation. Through strategic collaborations and pilot projects, Sci-Group is building the foundation for international growth and scalable impact.
Our vision is to set a new global standard for safe, efficient, and reproducible cryopreservation—unlocking value for medicine, science, and society.
Join us in shaping the future of safe and efficient cryopreservation. Become a partner in Sci-Group and unlock new opportunities in the rapidly expanding life sciences and cell therapy markets.
Interested? Leave your info here & we’ll get back to you.
https://sci-group.no/wp-content/uploads/2025/09/Cryopreservering-scaled.jpeg
1804
2560
wpx_
http://sci-group.no/wp-content/uploads/2025/08/SciGroup-logo-300x82.jpg
wpx_2025-08-14 12:09:342025-09-05 11:29:16Sci-Group’s solution: CryoEmbla
https://sci-group.no/wp-content/uploads/2025/08/lab-testing-scaled.jpeg
1280
2560
wpx_
http://sci-group.no/wp-content/uploads/2025/08/SciGroup-logo-300x82.jpg
wpx_2025-08-02 22:11:592025-09-05 12:10:31Who benefits from cryopreservation?
https://sci-group.no/wp-content/uploads/2025/08/The-history-of-cryopreservering-scaled.jpeg
1976
2560
wpx_
http://sci-group.no/wp-content/uploads/2025/08/SciGroup-logo-300x82.jpg
wpx_2025-08-01 22:21:062025-09-05 11:32:08The History of Cryopreservation“There are several challenges with cryopreservation that, if solved, would enable us to improve manufacturing and delivery, as well as allow for a more streamlined and efficient treatment of patients, and potentially also reduce toxicity. We therefore welcome all technological innovation in this area.”